Navigation Links
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
Date:11/30/2011

onviral gene therapy to prevent intimal hyperplasia 113

HSV-1 gene therapy to prevent intimal hyperplasia 114

Drug delivery devices for restenosis 114

Local drug delivery by catheter 114

Stenosis associated with stents 115

Absorbable metal stents 115

Drug-eluting stents 115

Various types of DES 116

CYPHER® sirolimus-eluting coronary stent 116

Dexamethasone-eluting stents 116

NO-generating stents 117

Paclitaxel-eluting stents 117

Sirolimus-eluting vs paclitaxel-eluting stents 118

Novel technologies for DES 118

Absorbable DES 118

Bio-absorbable low-dose DES 119

Drug-eluting stents coated with polymer surfaces 119

Endeavour DES 119

Stents for delivery of gene therapy 120

Stem cell-based stents 121

VAN 10-4 DES 121

Nanotechnology-based stents 122

Drugs encapsulated in biodegradable nanoparticles 122

Magnetic nanoparticle-coated DES 122

Magnetic nanoparticles encapsulating paclitaxel targeted to stents 123

Nanocoated DES 123

Nanopores to enhance compatibility of DES 124

Paclitaxel-encapsulated targeted lipid-polymeric nanoparticles 124

The ideal DES 124

Companies developing drug-eluting stents 125

Clinical trials of drug-eluting stents 126

Measurements used in clinical trials of DES 126

TAXUS paclitaxel-eluting stents 126

XIENCE™ V everolimus-eluting coronary stent 127

COSTAR II clinical trial 128

Endeavor RESOLUTE zotarolimus-eluting stent system 128

CUSTOM I clinical trial 129

NOBORI CORE Trial 129

LEADERS trial 130

Comparison of DES in clinical trials 130

Comparison of DES with competing technologies 131

DES versus coronary artery bypass graft 131

DES versus bare metal stents 131

Guidelines for DES vs BMS 134

DES vs BMS for off-label indications 134

<
'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
2. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
3. Study Shows Intradigms RNAi Nanoplex Technology To Be Effective Systemic siRNA Delivery Platform for the Treatment of Various Cancer Models
4. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
5. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
6. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
7. Phosphagenics Reports Positive Pre-clinical Results for Targeted Delivery of Lidocaine
8. TARGETED GENE DELIVERY IN VIVO: Rexin-G Monotherapy Reveals Significant Biological Activity Without Toxicity in Chemo-Resistant Metastatic Breast Cancer (ASCO 2008)
9. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
10. Phase I/II Study of Targeted Gene Delivery In Vivo - Intravenous Infusions of REXIN-G - Demonstrates Dose-Dependent Anti-Tumor Activity Without Toxicity in Patients With Progressive Chemo-Resistant Bone and Soft Tissue Sarcoma (ASCO 2008)
11. (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... LONDON , June 30, 2015 ... Street issued a survey to Rosacea sufferers as part of ... what treatments Rosacea sufferers found effective for their Rosacea. The ... age, and comprised 47% men and 53% women. ... of survey participants did not consider or attempt to visit ...
(Date:6/30/2015)... June 30, 2015 First Choice Wellness Care ... Astanza Duality and is the only clinic in the ... tattoo removal treatments. The practice has recently expanded their ... brand to showcase their focus in the procedure. They ... results, faster ink clearance, and superior service. ...
(Date:6/30/2015)... June 30, 2015  Avanir Pharmaceuticals, Inc. today ... showing that treatment with NUEDEXTA ® was ... of pseudobulbar affect (PBA) in patients with traumatic ... distressing condition characterized by sudden and uncontrollable outbursts ... diseases or brain injury. PRISM II is a ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 2First Choice Wellness Care Becomes Tallahassee Leader In Tattoo Removal With Astanza Duality 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7
... Top-line Data Expected in August -, EXTON, ... today the completion of the pivotal efficacy portion ... Isolagen,Therapy(TM) for the treatment of nasolabial folds, or ... the primary efficacy follow-up visit,and collation of this ...
... ... Professionals, VOORHEES, N.J., July 1 ... a wide spectrum of,severity, ranging from mild diarrhea to pseudomembranous colitis ... who develop an initial,case of CDI.(1) These patients are at increased ...
Cached Medicine Technology:Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 2Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles 3Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease 2
(Date:6/30/2015)... ... June 30, 2015 , ... Broadway by the Sea posted its newest ... family member testimonials. Medicare rated the care center as a five-star location based on ... to give future patients a firsthand look at the facility’s satisfied residents. , ...
(Date:6/30/2015)... ... ... From the moment a patient enters the office of Dr. Breiterman at ... and the luxury in which they are bathed. The office has always offered ... same experience, just better! , Their office is a state-of the-art facility using only ...
(Date:6/30/2015)... ... June 30, 2015 , ... MJH Associates ... HRA Healthcare Research & Analytics , a consultative healthcare market research practice that ... of businesses. HRA offers quantitative and qualitative, custom and multi-client primary market research ...
(Date:6/30/2015)... ... 30, 2015 , ... Independence Day weekend is more than just fireworks to ... off of July as National Hot Dog Month. Americans are expected to eat more ... of the year and enough to stretch from Washington D.C. to Los Angeles more ...
(Date:6/30/2015)... Nashville, Tennessee (PRWEB) , ... ... ... provider of CorrectChemo®, the drug response profiling test to help oncologists provide ... GeneSourceTM. , “The CorrectChemo® assay provides the oncologist with valuable insight ...
Breaking Medicine News(10 mins):Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 3Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 4Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 2Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 3
... Inc. (Nasdaq: NPSP ) announced today that it ... 2008 post-market. The,announcement will be followed by a conference ... participate in the conference call, dial (866) 510-0708 and ... the,same passcode. In addition, a live audio of the ...
... cardiovascular threats, study suggests , , THURSDAY, March 6 (HealthDay ... also be reducing their risk of heart attack and ... rheumatoid arthritis (RA), which causes pain, swelling, stiffness and ... risk of cardiovascular disease, because it can lead to ...
... Empire Blue Cross Blue Shield has,been fully cooperating ... issue to our attention., We were also surprised ... diligent in our efforts to determine whether the,information provided ... share,data with the Attorney General,s office in accordance with ...
... 418% versus 2006 ... 32% versus Q3 2007, VANCOUVER, March 6 /PRNewswire-FirstCall/ - ... $3.25 million for,the year ended December 31, 2007 compared to ... of 418%. The Company,s net loss,decreased to $3.5 million ($0.08) ...
... A study released this week from researchers ... California shows that non-polypoid colorectal neoplasms or flat colon ... and may have a greater association with cancer compared ... polyp. The study appears in the March 5 issue ...
... ,Smith & Nephew, Inc. (NYSE: SNN ; ... launch of the R3(TM) Acetabular System,an advanced multi-bearing ... The announcement was made during the 75th annual,American ... in the world, in San Francisco., The ...
Cached Medicine News:Health News:NPS Pharmaceuticals to Report 2007 Financial Results 2Health News:Rheumatoid Arthritis Drugs May Lower Heart Attack, Stroke Risk 2Health News:CRH Medical reports preliminary year end results 2Health News:CRH Medical reports preliminary year end results 3Health News:Colonoscopy used to identify and remove flat colon lesions 2Health News:Smith & Nephew Launches R3(TM) Acetabular System a Revolution in Hip Motion 2Health News:Smith & Nephew Launches R3(TM) Acetabular System a Revolution in Hip Motion 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: